Butyphthalide in Combination With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke
Clinical trial NCT03394950 · COMPLETED
Trial details
- NCT number
- NCT03394950
- Sponsor
- Hui-Sheng Chen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-25
- Primary completion
- 2021-05-29
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.